Navigation Links
Biological FM signal maintains inflammation in cancer, asthma and other diseases
Date:4/9/2009

A study published tomorrow (10 April) in Science examines a key player in conditions such as cancer, inflammatory bowel disease, rheumatoid arthritis and asthma and has shown that cells use a sophisticated communication system to coordinate responses to infection and maintain inflammation in the body. This system is now a target for designing drugs to treat these conditions.

Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC) and the Engineering and Physical Sciences Research Council (EPSRC) have combined biological experiments and mathematics to discover the secrets of NF-kappaB a biological machine that coordinates the setting up and maintenance of inflammation in the body by broadcasting a signal to surrounding cells.

The team from the Universities of Liverpool, Manchester and Warwick, along with scientists from pharmaceutical company AstraZeneca (AstraZeneca R & D, Charnwood) have used Systems biology a multidisciplinary approach that uses a combination of experimental and theoretical techniques to tackle biological problems to investigate the role of NF-kappaB.

Professor Michael White of the University of Liverpool, who led the research said: "We know that successive peaks and troughs in the amount of NF-kappaB forming a wave-like pattern over time can exert exquisite control over many biological processes that underlie the symptoms of inflammation. Furthermore, what we now see is that different cell processes are determined once they pick up the frequency of peaks and troughs in the NF-kappaB signal, just like tuning in to an FM radio signal."

Professor Douglas Kell, BBSRC Chief Executive and co-author of the paper in his previous role added: "This research is an example that shows truly integrated systems biology allowing us to get right to the bottom of a complex and important biological question i.e. can we better understand the fun
'/>"/>

Contact: Nancy Mendoza
press.office@bbsrc.ac.uk
01-793-413-355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Thomson Scientific Announces BONDplus for Biological Researchers
2. Neurobiological Technologies Reports Going Concern Qualification
3. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
4. Study questions assumptions about human sensitivity to biological motion
5. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
6. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
7. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
8. Biological markers of prostate cancer shed light on cancer burden faced by African-American men
9. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
10. Biological Link Between BRCA1 and Breast Cancer Detailed
11. Boston IVF is First in Northeast to Offer Pioneering Test of Womens Biological Clock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Nearly 50,000 veterans ... (BVA) in fiscal year 2012, with even more—54,033—expected by ... longer for a decision as the agency reports reduced ... provides veterans disability appeal services. The BVA ... Affairs. , Although the BVA received 49,611 cases in ...
(Date:5/22/2013)... A new study shows there is a gender ... American young children one that does not appear ... United States, girls had higher levels of self-regulation than ... their behavior and impulses, follow directions, and persist on ... and college completion, in past studies by Oregon State ...
(Date:5/22/2013)... 22, 2013 Successful Therapy for ... O’Laughlin Psychotherapy in the Silver Lake community of ... ages as progression to existing Parents and Couples ... into parenting therapy has always been suggested, but ... Psychotherapy now specializes in all aspects of ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Diversity Focus ... Handicap This! The performance promotes awareness that physical ... The Handicap This! performance will be held Friday, June ... School auditorium. Tickets for Handicap This! can be ... helps audiences measure the level to which their mind ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Today, Zane ... Alabama Health Insurance Exchange . Zane Benefits, which provides ... benefits, is the leader in defined contribution plans ... to Zane Benefits’ website, beginning in 2014 as part ... for individuals and small businesses will become available through ...
Breaking Medicine News(10 mins):Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3
... with $150K Donation to the University of Pittsburgh ... After losing a battle to Merkel Cell Carcinoma, an aggressive and deadly ... through a donation by the Al Copeland Foundation to the University ... Copeland Day on June 28, 2009. , , Al Copeland ...
... June 30 Biopure Corporation (Nasdaq: BPUR ) ... by letter dated June 24, 2009, that it is out of ... be delisted. The notice stated that the company no longer ... on the Nasdaq Capital Market. , , Nasdaq advised that ...
... reduced pain and restored mobility in tendinitis patients, study ... of people suffer from tendinitis of the rotator cuff, ... pain and restore mobility of the shoulder, Italian researchers ... tendinitis, which involves small calcium deposits within the tendons ...
... high percentage of women responded favorably to a bioidentical ... , MAPLE GROVE, Minn., June 30 Upsher-Smith ... to determine the response rates to three doses of ... 57th Annual Clinical Meeting of the American College of ...
... SOUTH SAN FRANCISCO, Calif., June 30 Hyperion Therapeutics, ... development of therapies that address critical unmet needs in ... has closed a $60 million Series C financing. New ... financing. Series A and B investors Highland Capital Partners, ...
... the most out of treatment during the summer months and beyond ... the arrival of summer means more time outdoors, with trips to ... more enjoyable than soaking up the sun and having fun with ... actually mean a worsening of symptoms and the need for extra ...
Cached Medicine News:Health News:Al Copeland Day Lives on Through Efforts To Cure Merkel Cell Carcinoma 2Health News:Al Copeland Day Lives on Through Efforts To Cure Merkel Cell Carcinoma 3Health News:Nonsurgical Treatment May Ease Rotator Cuff Injury 2Health News:New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause 2Health News:New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause 3Health News:New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause 4Health News:New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause 5Health News:Hyperion Therapeutics Raises $60 Million Series C 2Health News:Hyperion Therapeutics Raises $60 Million Series C 3Health News:Summertime Sun Exposure Can 'Burn' Acne Sufferers in More Ways than One 2Health News:Summertime Sun Exposure Can 'Burn' Acne Sufferers in More Ways than One 3
(Date:5/22/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB: GNBT) today announced three presentations demonstrating ... developed by its wholly-owned subsidiary, Antigen Express, Inc. ( ... annual meeting of the American Society of Clinical Oncology ... from May 31 through June 4, 2013. ...
(Date:5/22/2013)... 2013  Grifols, a global healthcare company based in ... a study demonstrating that a higher dose of PROLASTIN ... of the alpha 1 protein in patients with ... considered within the normal range for healthy individuals. AAT ... levels of the alpha 1 proteinase inhibitor (A1PI) ...
(Date:5/22/2013)... LAKES, N.J. , May 22, 2013  BD ... a leading global medical technology company, announced today the ... is BD,s fifth Sustainability Report and it continues to ... "We believe the principles of shared ... and addressing healthcare challenges of societies — are fundamental ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3
... Accuray Incorporated (Nasdaq: ARAY ) ... announced acquisition of TomoTherapy Incorporated (Nasdaq: TOMO). The ... best-in-class technologies to fight cancer.  The combined company ... leading-edge treatment solutions that revolve around the patient. ...
... 13, 2011 Guidelines that reduce the use of mechanical ... of respiratory support can profoundly affect those children,s outcomes while ... researchers at Children,s Hospital Boston. The team, ... Medicine at Children,s Hospital Boston and the Neonatal Intensive Care ...
Cached Medicine Technology:Accuray Successfully Completes Acquisition of TomoTherapy 2Accuray Successfully Completes Acquisition of TomoTherapy 3Accuray Successfully Completes Acquisition of TomoTherapy 4Guidelines for Ventilator Use Help Premature Infants Breathe Easier 2Guidelines for Ventilator Use Help Premature Infants Breathe Easier 3
... STAARVISC II is a sterile nonpyrogenic, ... hyaluronate. STAARVISC II contains 12 mg/ml of ... daltons) sodium hyaluronate dissolved in physiological saline. ... the viscosity is 105,000 cps (105 Pa ...
The Sonic WAVE™is the first market-ready Alternative to Ultrasound...
... The Stat Profile pHOx series consists of six ... and critical care profiles. Measured tests include pH, ... %, hematocrit, hemoglobin, sodium, potassium, ionized calcium, chloride, ... less than one minute. Its space saving design ...
... compact Sleepscan Traveler provides the ultimate flexibility ... PSG data in the home, a patient ... sleep studies utilize the same powerful Sleepscan ... Sleepscan Traveler studies take full advantage of ...
Medicine Products: